Related Experiment Video
Updated: Jan 29, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Bioluminescence Resonance Energy Transfer 2 (BRET2)-Based RAS Biosensors to Characterize RAS Inhibitors
Nicolas Bery1, Terence H Rabbitts1
1Weatherall Institute of Molecular Medicine, MRC Molecular Haematology Unit, University of Oxford, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
Abstract:
Protein-protein interactions (PPIs) are principle biological processes that control normal cell growth, differentiation, and homeostasis but are also crucial in diseases such as malignancy, neuropathy, and infection. Despite the importance of PPIs in biology, this target class has been very challenging to convert to therapeutics. In the last decade, much progress has been made in the inhibition of PPIs involved in diseases, but many remain difficult such as RAS-effector interactions in cancers. We describe here a protocol for using Bioluminescence Resonance Energy Transfer 2 (BRET2)-based RAS biosensors to detect and characterize RAS PPI inhibition by macromolecules and small molecules. This method could be extended to any other small GTPases or any other PPIs of interest. © 2019 by John Wiley & Sons, Inc.
Insights
This study introduces a novel Bioluminescence Resonance Energy Transfer 2 (BRET2)-based RAS biosensor. This method effectively detects and characterizes RAS protein-protein interaction inhibition for potential cancer therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Protein-protein interactions (PPIs) are vital for cellular functions and implicated in diseases like cancer.
- Targeting PPIs for therapeutic intervention remains challenging, particularly RAS-effector interactions in cancers.
- Existing methods for studying PPIs have limitations in characterizing inhibitors.
Purpose of the Study:
- To present a protocol for a novel Bioluminescence Resonance Energy Transfer 2 (BRET2)-based RAS biosensor.
- To demonstrate the utility of this biosensor for detecting and characterizing RAS PPI inhibition.
- To provide a versatile platform applicable to other small GTPases and PPIs.
Main Methods:
- Development and application of BRET2-based biosensors specific for RAS proteins.
- Utilizing the BRET2 system to monitor RAS protein-protein interactions in real-time.
- Characterization of inhibition of RAS PPIs by both small molecules and macromolecules.
Main Results:
- The BRET2-based RAS biosensor successfully detected and characterized RAS PPI inhibition.
- The protocol provides a sensitive and specific method for evaluating potential PPI inhibitors.
- The approach is adaptable for studying other small GTPase interactions.
Conclusions:
- BRET2-based RAS biosensors offer a powerful tool for studying RAS PPIs and drug discovery.
- This method facilitates the development of novel therapeutics targeting challenging PPIs.
- The protocol's adaptability makes it valuable for broader PPI research.
More Related Videos
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
08:53Visualizing Cellular Gibberellin Levels Using the nlsGPS1 Förster Resonance Energy Transfer (FRET) Biosensor
Published on: January 12, 2019
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Resonance
Energy Transfer in Chemical Reactions
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Ionization Energy